Overview

KITS Study -Ketorolac In Tonsillectomy Surgery: a Double Blinded, Randomized Clinical Trial

Status:
Terminated
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
Our group wishes to test the novel hypothesis that intraoperative use of ketorolac in pediatric patients undergoing tonsillectomy reduces post-operative nausea and vomiting, postoperative pain scores, subsequent narcotic use, and length of hospital stay without adversely affecting post-operative bleed risk, when compared to placebo, in a double-blind, randomized controlled trial.
Phase:
Phase 2
Details
Lead Sponsor:
University of Alberta
Treatments:
Ketorolac
Ketorolac Tromethamine